Jazz Pharma Shares Jump on Narcolepsy Treatment Patent

Jazz Pharma Shares Jump on Narcolepsy Treatment Patent

Filed under: drug treatment news 2012

Shares of drug maker Jazz Pharmaceuticals (JAZZ) jumped 9.6% on Tuesday following the announcement of a new patent issue for Xyrem, a treatment for the sleep disorder narcolepsy. The patent … The sale is expected to close in the fourth quarter of 2012.
Read more on Barron’s (blog)

 

Eisai launches epilepsy drug Fycompa in UK

Filed under: drug treatment news 2012

Eisai has made the UK the first country in Europe to launch its novel epilepsy treatment Fycompa. Recommended by the European Medicines Agency (EMA) in May, 2012, the drug is the first in a new class of treatment for uncontrolled partial epilepsy and …
Read more on PMLiVE

 

Analysis: Use of pill to prevent HIV may be limited in US

Filed under: drug treatment news 2012

Any use of Truvada for preventing HIV infection "seems to be a rounding error in our estimates for treating HIV," he said, projecting Gilead's 2012 sales from the drug at $ 3.1 billion. RBC Capital Markets described the prevention indication as a "niche …
Read more on Reuters

 

Denmark's Zealand Pharma starts Phase I diabetes drug trials

Filed under: drug treatment news 2012

The milestone payment would help to support future development of other diabetes drugs and treatments for people suffering from obesity, Zealand Pharma said. It did not reveal the size of the payment from Boehringer Ingelheim, which it teamed up with …
Read more on WHTC

 

Leave a Reply

Your email address will not be published. Required fields are marked *